Loading…
DeviceTalks Boston has ended

DeviceTalks is a conversation among leaders. It’s an evening for an exchange of ideas, insight and contacts among the pioneers of the medical technology industry. Formerly known as the Big 100, this event is held annually in Boston, Orange County and the Twin Cities.



On July 15th, you’re invited to join us for a discussion with some of the area’s most innovative and influential leaders, including Brian Concannon, CEO, Haemonetics; Duane DeSisto, CEO, Insulet; Carmichael Roberts, General Partner North Bridge Venbtures and Founder of  480 Biomedical, Arsenal Medical, Diagnostics for All, MC10 and Dr. Charles Carignan.



DeviceTalks also features four panel discussions on hot issues facing medtech companies. The descriptions of which can be found below. When you register you are automatically allowed entry into any of the panels listed.

avatar for Maria Palasis

Maria Palasis

Arsenal Medical
CEO
Watertown, MA
Maria Palasis is President and Chief Executive Officer of 480 Biomedical. Prior to joining 480 Biomedical, Dr. Palasis was R&D director at Boston Scientific, where she managed a portfolio of external biotech and medical device investments and was responsible for the development of new convergence products. Dr. Palasis was as an early member of the team that created the TAXUS® drug-eluting stent, the single most important revenue generator for Boston Scientific at $3B/year. She held a number of positions within Boston Scientific that included strategic planning for the development of advanced combination therapies, managing alliances through clinical trials, and building and directing the company’s centralized infrastructure for the biological testing of drug eluting stent technologies. Maria received her Bachelor of Science and doctorate in chemical engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine.